Jane Street’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-37,400
| Closed | -$4.93M | – | 11371 |
|
|
2025
Q1 | $4.93M | Buy |
37,400
+26,000
| +228% | +$3.24M | ﹤0.01% | 2957 |
|
|
2024
Q4 | $952K | Sell |
11,400
-8,100
| -42% | -$666K | ﹤0.01% | 5485 |
|
|
2024
Q3 | $1.43M | Buy |
19,500
+100
| +0.5% | +$7.52K | ﹤0.01% | 5163 |
|
|
2024
Q2 | $1.33M | Sell |
19,400
-33,400
| -63% | -$2.32M | ﹤0.01% | 5222 |
|
|
2024
Q1 | $3.65M | Buy |
52,800
+2,700
| +5% | +$186K | ﹤0.01% | 3093 |
|
|
2023
Q4 | $3.59M | Buy |
50,100
+26,200
| +110% | +$1.51M | ﹤0.01% | 3345 |
|
|
2023
Q3 | $1.24M | Buy |
23,900
+11,000
| +85% | +$641K | ﹤0.01% | 4844 |
|
|
2023
Q2 | $817K | Sell |
12,900
-167,600
| -93% | -$10.4M | ﹤0.01% | 5548 |
|
|
2023
Q1 | $9.77M | Buy |
180,500
+143,300
| +385% | +$6.93M | ﹤0.01% | 1666 |
|
|
2022
Q4 | $1.97M | Sell |
37,200
-83,700
| -69% | -$4.19M | ﹤0.01% | 3896 |
|
|
2022
Q3 | $5.63M | Sell |
120,900
-88,300
| -42% | -$4.61M | ﹤0.01% | 2418 |
|
|
2022
Q2 | $11.9M | Buy |
209,200
+135,200
| +183% | +$7.67M | 0.01% | 1550 |
|
|
2022
Q1 | $4.53M | Sell |
74,000
-48,800
| -40% | -$2.53M | ﹤0.01% | 3193 |
|
|
2021
Q4 | $6.43M | Buy |
122,800
+70,400
| +134% | +$2.96M | ﹤0.01% | 2474 |
|
|
2021
Q3 | $1.95M | Buy |
52,400
+17,900
| +52% | +$622K | ﹤0.01% | 4525 |
|
|
2021
Q2 | $1.41M | Buy |
34,500
+23,600
| +217% | +$872K | ﹤0.01% | 5065 |
|
|
2021
Q1 | $370K | Sell |
10,900
-12,900
| -54% | -$448K | ﹤0.01% | 7357 |
|
|
2020
Q4 | $757K | Sell |
23,800
-57,300
| -71% | -$1.51M | ﹤0.01% | 5113 |
|
|
2020
Q3 | $2.08M | Sell |
81,100
-147,500
| -65% | -$3.37M | ﹤0.01% | 2976 |
|
|
2020
Q2 | $5.87M | Buy |
228,600
+215,300
| +1,619% | +$4.36M | ﹤0.01% | 1670 |
|
|
2020
Q1 | $204K | Sell |
13,300
-149,900
| -92% | -$3.26M | ﹤0.01% | 4633 |
|
|
2019
Q4 | $5.6M | Buy |
+163,200
| New | +$1.96M | 0.01% | 988 |
|
|
2017
Q2 | – | Sell |
-36,900
| Closed | -$600K | – | 4983 |
|
|
2017
Q1 | $600K | Buy |
+36,900
| New | +$534K | ﹤0.01% | 2665 |
|
Other funds holding ITCI
KIM
HNB
Jane Street's ITCI Position: Q2 2025 in Review
Jane Street sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 132,909 shares — an estimated $17.5M sold.
Jane Street first reported a position in ITCI in Q2 2014 and held it in 28 quarters. The position peaked at $33M in Q2 2024. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.
- Jane Street reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
- Jane Street sold 132,909 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $17.5M.
- Jane Street first reported a position in Intra-Cellular Therapies Inc. in Q2 2014 and held it in 28 quarters.
- Jane Street's Intra-Cellular Therapies Inc. position peaked at $33M in Q2 2024.
- 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.
Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.